MARATTO

article · BMC Cancer

The impact of loco-regional treatment modality on the outcomes in breast cancer patients younger than forty years of age

20241 citationOpen accessZagazig University

Abstract

For patients younger than 40 years of age, similar LRR and overall survival outcomes were achieved using BCT, M or MRX. Young age at diagnosis should not be used alone in recommending one loco-regional treatment approach over the others.

Research topics

  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • BRCA gene mutations in cancer

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1186/s12885-024-12325-3

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.